Genetics Generation Advancement Corp.

NT$33.40As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4160Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 4.33%
Div yield 5.27%
ROE 3.74%
Diagnostics & Research
Beta (5Y) 0.36
PE TTM 52.31
TSR TTM (37.73%)
Mkt cap NT$935.7M
ROIC 0.52%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$43
28.90%
(62.32%)
Hold 1|4|11|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.57
0.57
0.58
0.59
20.52%
9.26%
15.29%
14.62%
RevenueNT$M
60.80
62.46
63.00
63.62
6.43%
4.93%
5.57%
3.39%
Peers (US$28.26M)
Cap (US$)
PE
21.39M
102.4x
Capital
TTM
5Y
10Y
Leveragex
0.361
0.133
0.132
EBIT/Intx
0.628
1.482
1.610
Own earn%
157.40
55.09
56.25
Sh yield%
26.88
33.85
31.90
Owners
Insiders/Inst%
9.14
77.50
Short interest%
4.70
SBC / revenue%
1.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
12–19
$1 testx
—
Incr. ROIC%
2